April 27, 2026 Four Models Assemble at Exclusive Preview Event as Global Partners Witness EXEED’s Premium Strategy Reach New Heights
April 27, 2026 OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101) for Prevention of Organ Rejection in Heart Transplant Patients
